Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Di Carlo

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Oncoimmunology|April 18, 2014
Interleukin-30: A novel microenvironmental hallmark of prostate cancer progressionEmma Di Carlo
Experimental Hematology & Oncology|July 3, 2026
Targeting the cancer metabolism-immunity interface: update and perspectivesEmma Di Carlo
Cells|March 8, 2020
Decoding the Role of Interleukin-30 in the Crosstalk Between Cancer and Myeloid CellsEmma Di Carlo
Journal of Biomedical Science|January 6, 2026
Tumor-on-chip's alliance with molecular pathology against metastatic diseaseEmma Di Carlo
Medcomm|April 23, 2026
Early Cancer Detection: What's Going on and What's NextEmma Di Carlo
American Journal of Respiratory and Critical Care Medicine|July 25, 2009
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotypeCarlo Sorrentino, Emma Di Carlo
Antioxidants (Basel, Switzerland)|September 28, 2024
Oxidative Stress and Age-Related TumorsEmma Di Carlo, Carlo Sorrentino
Journal of Translational Medicine|September 5, 2024
The multifaceted role of the stroma in the healthy prostate and prostate cancerEmma Di Carlo, Carlo Sorrentino
Biomarker Research|December 19, 2024
State of the art CRISPR-based strategies for cancer diagnostics and treatmentEmma Di Carlo, Carlo Sorrentino
Cancers|June 10, 2023
Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future ChallengesCarlo Sorrentino, Emma Di Carlo
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Oncoimmunology|April 18, 2014
Interleukin-30: A novel microenvironmental hallmark of prostate cancer progressionEmma Di Carlo
Experimental Hematology & Oncology|July 3, 2026
Targeting the cancer metabolism-immunity interface: update and perspectivesEmma Di Carlo
Cells|March 8, 2020
Decoding the Role of Interleukin-30 in the Crosstalk Between Cancer and Myeloid CellsEmma Di Carlo
Journal of Biomedical Science|January 6, 2026
Tumor-on-chip's alliance with molecular pathology against metastatic diseaseEmma Di Carlo
Medcomm|April 23, 2026
Early Cancer Detection: What's Going on and What's NextEmma Di Carlo
American Journal of Respiratory and Critical Care Medicine|July 25, 2009
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotypeCarlo Sorrentino, Emma Di Carlo
Antioxidants (Basel, Switzerland)|September 28, 2024
Oxidative Stress and Age-Related TumorsEmma Di Carlo, Carlo Sorrentino
Journal of Translational Medicine|September 5, 2024
The multifaceted role of the stroma in the healthy prostate and prostate cancerEmma Di Carlo, Carlo Sorrentino
Biomarker Research|December 19, 2024
State of the art CRISPR-based strategies for cancer diagnostics and treatmentEmma Di Carlo, Carlo Sorrentino
Cancers|June 10, 2023
Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future ChallengesCarlo Sorrentino, Emma Di Carlo
Pageof 10